jueves, 19 de septiembre de 2019

Databases for Research and Development - Volume 25, Number 10—October 2019 - Emerging Infectious Diseases journal - CDC

Databases for Research and Development - Volume 25, Number 10—October 2019 - Emerging Infectious Diseases journal - CDC

Issue Cover for Volume 25, Number 10—October 2019

Volume 25, Number 10—October 2019
Letter

Databases for Research and Development

I welcome the findings of Mehand et al. in putting together a methodology that can prioritize emerging infectious diseases in need of research and development (1). These approaches are vital in establishing how global research funders and research institutions can best contribute to establishing a knowledge base around what diseases to address and how.
There is also a distinct need to understand ongoing research portfolios at international and national levels. The data emerging from these projects can provide further knowledge and impact in health policy and inform further research priorities.
Our ongoing project involves the Research Investments in Global Health (ResIn) study. ResIn has described research portfolios for cancer and infectious disease research in the United Kingdom (2,3). Internationally, the study has covered investments into global pneumonia research (4) and malaria research across Africa (5). Findings have examined, for example, the burden of disease alongside levels of investment, as well as providing informed comment on research gaps. ResIn also considers how best to implement findings from a research database into health policy and practice, and has presented results and sought opinion from meetings with key stakeholders, including the World Health Organization (WHO), European Commission, and Wellcome Trust.
I encourage WHO and other stakeholders to consider an open-access global research investments portfolio for all areas of health, using open datasets to describe spending on research alongside other areas, such as burden of disease. Alongside the WHO R&D Blueprint (https://www.who.int/blueprintExternal Link), this resource can support decision-making around research knowledge and innovation.
Michael G. HeadComments to Author 
Author affiliation: University of Southampton, Hampshire, UK

References

  1. Mehand  MS, Millett  P, Al-Shorbaji  F, Roth  C, Kieny  MP, Murgue  B. World Health Organization methodology to prioritize emerging infectious diseases in need of research and development. Emerg Infect Dis. 2018;24:24. DOIExternal LinkPubMedExternal Link
  2. Maruthappu  M, Head  MG, Zhou  CD, Gilbert  BJ, El-Harasis  MA, Raine  R, et al. Investments in cancer research awarded to UK institutions and the global burden of cancer 2000-2013: a systematic analysis. BMJ Open. 2017;7:e013936. DOIExternal LinkPubMedExternal Link
  3. Head  MG, Fitchett  JR, Nageshwaran  V, Kumari  N, Hayward  A, Atun  R. Research investments in global health: a systematic analysis of UK infectious disease research funding and global health metrics, 1997–2013. EBioMedicine. 2015;3:180–90. DOIExternal LinkPubMedExternal Link
  4. Brown  RJ, Head  MG. Sizing up pneumonia researchExternal Link. Southampton (United Kingdom): University of Southampton; 2018 [cited 2019 Aug 3]. https://figshare.com/articles/Sizing_Up_Pneumonia_Investment/6143060External Link
  5. Head  MG, Goss  S, Gelister  Y, Alegana  V, Brown  RJ, Clarke  SC, et al. Global funding trends for malaria research in sub-Saharan Africa: a systematic analysis. Lancet Glob Health. 2017;5:e772–81. DOIExternal LinkPubMedExternal Link
Cite This Article

DOI: 10.3201/eid2510.181411
Original Publication Date: 8/30/2019

No hay comentarios:

Publicar un comentario